Anthraquinone

Anthraquinone

SCHEMBL3670422

CCCc1c(C(=O)O)c(O)cc2c1C(=O)c1c(O)cccc1C2=O.O=C1c2ccccc2C(=O)c2ccccc21

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JUN P05412 1/20 0.95
SLC37A4 O43826 7/20 0.83
ALDH1A1 P00352 3/20 0.52
MAPT P10636 3/20 0.52
TSHR P16473 3/20 0.52
TDP1 Q9NUW8 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
TTR P02766 2/20 0.52
KDM4E B2RXH2 2/20 0.52
CYP3A4 P08684 2/20 0.52
RECQL P46063 2/20 0.52
LMNA P02545 2/20 0.52
HPGD P15428 2/20 0.52
ALOX15 P16050 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
HSD17B10 Q99714 2/20 0.52
FTO Q9C0B1 2/20 0.52
BCHE P06276 1/20 0.52
POLB P06746 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16431884 0.98 JUN (1.00) JUNSLC37A4ALDH1A1MAPTTSHR
SCHEMBL3670424 0.84 JUN (0.68) JUNSLC37A4ALDH1A1MAPTTSHR
SCHEMBL2314224 0.80 JUN (0.69) JUNSLC37A4ALDH1A1MAPTTSHR
SCHEMBL5142787 0.78 SLC37A4 (0.67) JUNSLC37A4ALDH1A1MAPTTSHR
SCHEMBL30848230 0.78 SLC37A4 (0.67) JUNSLC37A4ALDH1A1MAPTTSHR
SCHEMBL16226021 0.77 JUN (0.65) JUNSLC37A4ALDH1A1MAPTTSHR
SCHEMBL16431129 0.76 SLC37A4 (0.74) JUNSLC37A4ALDH1A1MAPTTSHR
SCHEMBL16227089 0.75 JUN (0.62) JUNSLC37A4MEN1KMT2AELANE
Rhein SCHEMBL4417951 0.72 TTR (0.94) ALDH1A1MAPTTSHRTDP1MEN1
SCHEMBL17866722 0.72 JUN (0.56) JUNSLC37A4ALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795302-B2 Use of compositions for treating rosacea THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-09-14 US disclosed
US-20080070874-A1 using retinoid or tetracycline as bactericide, benzoyl peroxide as metalloproteinases (MMPs) and neutrophil elastase inhibitors; antiscarring agents; reduction in procollagen biosynthesis THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2008-03-20 US disclosed
US-7268148-B2 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2007-09-11 US disclosed
US-7078048-B2 Method and compositions for treating rosacea THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2006-07-18 US disclosed
US-20060078582-A1 Use of compositions for treating rosacea THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2006-04-13 US disclosed
EP-1385496-A4 USE OF COMPOSITIONS FOR TREATING ROSACEA UNIV MICHIGAN (US) 2006-03-29 EP disclosed
US-20060009494-A1 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes VOORHEES JOHN J 2006-01-12 US disclosed
US-20050277695-A1 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes VOORHEES JOHN J 2005-12-15 US disclosed
US-20040235950-A1 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes REGENTS OF THE UNIVERSITY OF MICHIGAN, THE 2004-11-25 US disclosed
EP-1385496-A2 USE OF COMPOSITIONS FOR TREATING ROSACEA THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2004-02-04 EP disclosed
EP-1284721-A2 COMPOSITIONS AND METHODS FOR USE AGAINST ACNE-INDUCED INFLAMMATION AND DERMAL MATRIX-DEGRADING ENZYMES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2003-02-26 EP disclosed
US-20020183399-A1 Method and compositions for treating rosacea REGENTS OF THE UNIVERSITY OF MICHIGAN, THE 2002-12-05 US disclosed
WO-2002089743-A2 USE OF COMPOSITIONS FOR TREATING ROSACEA THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2002-11-14 WO disclosed
WO-2001089502-A2 COMPOSITIONS AND METHODS FOR USE AGAINST ACNE-INDUCED INFLAMMATION AND DERMAL MATRIX-DEGRADING ENZYMES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2001-11-29 WO disclosed